SauravChatterjeeMD
Cardiology • New York, NYAdult Congenital Heart Disease, Interventional Cardiology, Peripheral Endovascular Interventional Cardiology
Staff Interventional Cardiologist and Assistant Professor of Medicine
Dr. Chatterjee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
124 W 60th St
APT 18H
New York, NY 10023Phone+1 859-433-5593Fax+1 347-244-7148
Education & Training
Temple University HospitalFellowship, Interventional Cardiology, 2016 - 2017
Icahn School of Medicine at Mount Sinai/Morningside/BronxCareFellowship, Cardiovascular Disease, 2013 - 2016
Maimonides Medical CenterResidency, Internal Medicine, 2009 - 2012
University of Calcutta School of MedicineClass of 2007
Calcutta National Medical CollegeClass of 2006
Certifications & Licensure
MA State Medical License 2019 - 2026
CT State Medical License 2017 - 2025
NJ State Medical License 2024 - 2025
NY State Medical License 2012 - 2025
PA State Medical License 2014 - 2021
RI State Medical License 2012 - 2013- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- 222 citationsInterventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American He...Jay Giri, Akhilesh K. Sista, Ido Weinberg, Clive Kearon, Dharam J. Kumbhani
Circulation. 2019-11-12 - 181 citationsGlucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trialsJacob A. Udell, Matthew A. Cavender, Deepak L. Bhatt, Saurav Chatterjee, Michael E. Farkouh
The Lancet. Diabetes & Endocrinology. 2015-05-01 - 524 citationsThrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial Hemorrhage: A Meta-analysisSaurav Chatterjee, Anasua Chakraborty, Ido Weinberg, Mitul B. Kadakia, Robert L. Wilensky
JAMA. 2014-06-18
Press Mentions
How Applicable Is ISCHEMIA Trial to U.S. Clinical Practice?November 5th, 2021- About One-Third of US Patients Undergoing PCI for SIHD Meet ISCHEMIA Trial Criteria, NCDR Study ShowsNovember 3rd, 2021
- How Applicable Is ISCHEMIA Trial to US Clinical Practice?November 2nd, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
